Article Figures & Data
Figures
- Figure 1.
Effect of Alirocumab and Ezetimibe on LDL-C Levels at 24 Weeks
LDL-C, low-density lipoprotein cholesterol; LS, least squares (a statistical mean estimated from a linear model); SE, standard error.
Reproduced with permission from CP Cannon, MD.
Tools
ODYSSEY COMBO II: Alirocumab Significantly Improves Cholesterol Levels in Patients with High CV Risk
Permalink:
Table of contents
Cited By...
- No citing articles found.